Get startedLog in
    Picture of Alphamab Oncology logo

    9966 — Alphamab Oncology News Story

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMid CapSucker Stock
    All News

    Brief: Alphamab Oncology Says Unit Got U.S. FDA Approval To Proceed With Phase II Clinical Trial Of KN046

    Picture of Alphamab Oncology logoAlphamab Oncology
    15/04/2020 16:03
    April 15 (Reuters) - Alphamab Oncology  9966.HK :
    * UNIT GOT APPROVAL NOTIFICATION FROM U.S. FDA THAT IT IS
SAFE TO
PROCEED WITH PHASE II CLINICAL TRIAL OF BISPECIFIC ANTIBODY
KN046

Source text for Eikon:  urn:newsml:reuters.com:*:nHKS5q9krt
Further company coverage:  9966.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Alphamab Oncology

    See all news